The role of testosterone in erectile dysfunction

[1]  P. Palego,et al.  Metabolic Syndrome and Erectile Dysfunction , 2011, Diabetes Care.

[2]  Ross Ward,et al.  American Association of Clinical Endocrinologists , 2011 .

[3]  A. Silman,et al.  Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). , 2010, The journal of sexual medicine.

[4]  G. Forti,et al.  Autoeroticism, mental health, and organic disturbances in patients with erectile dysfunction. , 2010, The journal of sexual medicine.

[5]  F. Greenway,et al.  An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: , 2010 .

[6]  G. Balercia,et al.  The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. , 2009, International journal of andrology.

[7]  G. Forti,et al.  Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. , 2009, International journal of andrology.

[8]  E. Sarchielli,et al.  Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. , 2009, The journal of sexual medicine.

[9]  A. Traish,et al.  The dark side of testosterone deficiency: III. Cardiovascular disease. , 2009, Journal of andrology.

[10]  G. Forti,et al.  Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. , 2009, The journal of sexual medicine.

[11]  G. Forti,et al.  Recognising late-onset hypogonadism: a difficult task for sexual health care , 2009 .

[12]  C. Faravelli,et al.  Hysterical traits are not from the uterus but from the testis: a study in men with sexual dysfunction. , 2009, The journal of sexual medicine.

[13]  P. Cohen.  The metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone , 2009, Andrologia.

[14]  Karen A Robinson,et al.  Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. , 2009, The Journal of clinical endocrinology and metabolism.

[15]  M. Carini,et al.  Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism. , 2009, The journal of sexual medicine.

[16]  I. Eardley,et al.  376 WHAT IS THE THRESHOLD LEVEL OF THE PDE5 INHIBITORS' TESTOSTERONE-DEPENDENCE IN MEN? A DOUBLE BLIND PLACEBO-CONTROLED TRIAL OF TESTOSTERONE GEL ADDITION IN MEN WITH ED NON RESPONDING TO TADALAFIL 10 MG ONCE A DAY ALONE , 2009 .

[17]  G. Forti,et al.  Psychobiological correlates of extramarital affairs and differences between stable and occasional infidelity among men with sexual dysfunctions. , 2009, The journal of sexual medicine.

[18]  R. Swerdloff,et al.  Obesity, low testosterone levels and erectile dysfunction , 2009, International Journal of Impotence Research.

[19]  A. Traish,et al.  The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. , 2008, Journal of andrology.

[20]  I. Thompson,et al.  Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. , 2006, Journal of andrology.

[21]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[22]  J. Kaufman,et al.  Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. , 2009, European urology.

[23]  M. Berridge,et al.  Smooth muscle cell calcium activation mechanisms , 2008, The Journal of physiology.

[24]  Pranjal H. Mehta,et al.  The social endocrinology of dominance: basal testosterone predicts cortisol changes and behavior following victory and defeat. , 2008, Journal of personality and social psychology.

[25]  T. Hwang,et al.  The relationship between hypogonadism and erectile dysfunction , 2008, International Journal of Impotence Research.

[26]  G. Forti,et al.  Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome , 2008, The aging male : the official journal of the International Society for the Study of the Aging Male.

[27]  R. Shabsigh,et al.  Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. , 2008, The Journal of urology.

[28]  A. Dobs,et al.  Current and future testosterone delivery systems for treatment of the hypogonadal male. , 2008, Expert opinion on drug delivery.

[29]  S. Basaria,et al.  The latest options and future agents for treating male hypogonadism , 2007, Expert opinion on pharmacotherapy.

[30]  G. Forti,et al.  Which patients with sexual dysfunction are suitable for testosterone replacement therapy? , 2007, Journal of endocrinological investigation.

[31]  G. Balercia,et al.  Effect of hyperprolactinemia in male patients consulting for sexual dysfunction. , 2007, The journal of sexual medicine.

[32]  D. Swaab.  Sexual differentiation of the brain and behavior. , 2007, Best practice & research. Clinical endocrinology & metabolism.

[33]  G. Vannelli,et al.  Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. , 2007, The journal of sexual medicine.

[34]  S. Anders,et al.  Multiple partners are associated with higher testosterone in North American men and women , 2007, Hormones and Behavior.

[35]  S. Bhasin,et al.  Sexual dysfunction in men and women with endocrine disorders , 2007, The Lancet.

[36]  K. McVary.  Clinical practice. Erectile dysfunction. , 2007, The New England journal of medicine.

[37]  A. Seftel,et al.  Testosterone replacement therapy for male hypogonadism: Part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents , 2007, International Journal of Impotence Research.

[38]  V. Montori,et al.  Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. , 2007, Mayo Clinic proceedings.

[39]  J. Archer.  Testosterone and human aggression: an evaluation of the challenge hypothesis , 2006, Neuroscience & Biobehavioral Reviews.

[40]  J. Buvat,et al.  Significance of hypogonadism in erectile dysfunction , 2006, World Journal of Urology.

[41]  E. Greco,et al.  Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. , 2006, European urology.

[42]  G. Balercia,et al.  Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. , 2006, European urology.

[43]  G. Balercia,et al.  ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. , 2006, The journal of sexual medicine.

[44]  V. Montori,et al.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[45]  F. Saad,et al.  Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open‐label uncontrolled study , 2006, Andrologia.

[46]  H. Perry,et al.  Comparison of screening questionnaires for the diagnosis of hypogonadism. , 2006, Maturitas.

[47]  A. Granata,et al.  Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections. , 2006, Journal of andrology.

[48]  Xin-hua Zhang,et al.  Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. , 2006, The journal of sexual medicine.

[49]  B. Rosenthal,et al.  Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone. , 2006, Urology.

[50]  G. Balercia,et al.  Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic , 2006, International Journal of Impotence Research.

[51]  T. Tsai,et al.  Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone , 2006, International Journal of Impotence Research.

[52]  C. Ersoy,et al.  Efficacy of sildenafil in male dialysis patients with erectile dysfunction unresponsive to erythropoietin and/or testosterone treatments , 2006, International Journal of Impotence Research.

[53]  A. L. A S T A I,et al.  Erectile dysfunction. , 2006, Harvard men's health watch.

[54]  G. Balercia,et al.  The impotent couple: low desire. , 2005, International journal of andrology.

[55]  A. Lenzi,et al.  Effects of testosterone on sexual function in men: results of a meta‐analysis , 2005, Clinical endocrinology.

[56]  J. Bancroft.  The endocrinology of sexual arousal. , 2005, The Journal of endocrinology.

[57]  R. Swerdloff,et al.  Advances in male hormone substitution therapy , 2005, Expert opinion on pharmacotherapy.

[58]  R. Shamloul,et al.  Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: a pilot study. , 2005, The journal of sexual medicine.

[59]  P. Toselli,et al.  Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency. , 2005, Journal of andrology.

[60]  G. Vannelli,et al.  Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. , 2005, European urology.

[61]  M. Sofer,et al.  Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed? , 2005, The Journal of urology.

[62]  T. Ebert,et al.  The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel. , 2005, European urology.

[63]  G. Forti,et al.  Testosterone and sexual activity. , 2005, Journal of endocrinological investigation.

[64]  A. Colao,et al.  PRL Secreting Adenomas in Male Patients , 2005, Pituitary.

[65]  S. Glina.  Testosterone and erectile dysfunction , 2004 .

[66]  D. Klein,et al.  AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. , 2004, The Journal of clinical endocrinology and metabolism.

[67]  P. Dandona,et al.  Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[68]  F. Saad,et al.  Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency? , 2004, The aging male : the official journal of the International Society for the Study of the Aging Male.

[69]  A. Lenzi,et al.  Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels , 2004, Clinical endocrinology.

[70]  J. Kaufman,et al.  Endocrine aspects of sexual dysfunction in men. , 2004, The journal of sexual medicine.

[71]  C. Foresta,et al.  Role of androgens in erectile function. , 2004, The Journal of urology.

[72]  G. Forti,et al.  Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction , 2004, International Journal of Impotence Research.

[73]  J. Archer,et al.  Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study. , 2004, The Journal of clinical endocrinology and metabolism.

[74]  M. Giorgi,et al.  Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. , 2004, Endocrinology.

[75]  G. Cavallini,et al.  Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. , 2004, Urology.

[76]  W. Lees,et al.  A novel therapy with testosterone and sildenafil for erectile dysfunction in patients on renal dialysis or after renal transplantation , 2004, Journal of Family Planning and Reproductive Health Care.

[77]  David Handelsman,et al.  Testosterone: Pharmacology of testosterone preparations , 2004 .

[78]  J. Buvat.  Hyperprolactinemia and sexual function in men: a short review , 2003, International Journal of Impotence Research.

[79]  R. Burcelin,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0457 Gonadotropin-Releasing Hormone Secretion from Hypothalamic Neurons: Stimulation by Insulin and , 2022 .

[80]  G. Forti,et al.  Structured interview on erectile dysfunction (SIEDY©): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction , 2003, International Journal of Impotence Research.

[81]  C. Wingard,et al.  Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[82]  A. Lenzi,et al.  Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction , 2003, Clinical endocrinology.

[83]  G. Katsiya,et al.  Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone , 2003, The aging male : the official journal of the International Society for the Study of the Aging Male.

[84]  S. Petak,et al.  American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[85]  P. Lavie,et al.  Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. , 2002, The Journal of clinical endocrinology and metabolism.

[86]  F. Trimarchi,et al.  Sexual inactivity results in reversible reduction of LH bioavailability , 2002, International Journal of Impotence Research.

[87]  P. Sogari,et al.  The relationship of serum testosterone to erectile function in normal aging men. , 2002, The Journal of urology.

[88]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[89]  R. Klein,et al.  Role of brain insulin receptor in control of body weight and reproduction. , 2006, Science.

[90]  J. Mckinlay,et al.  Construction and field validation of a self‐administered screener for testosterone deficiency (hypogonadism) in ageing men , 2000, Clinical endocrinology.

[91]  H. Perry,et al.  Validation of a screening questionnaire for androgen deficiency in aging males. , 2000, Metabolism: clinical and experimental.

[92]  A. Rademaker,et al.  Testosterone supplementation for erectile dysfunction: results of a meta-analysis. , 2000, The Journal of urology.

[93]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[94]  D. Giesen,et al.  Sexual Infidelity among Married and Cohabiting Americans , 2000 .

[95]  A. Burnett.  Effects of castration and androgen replacement on erectile function in a rabbit model. , 2000, International journal of impotence research.

[96]  F. Trimarchi,et al.  Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone. , 1999, International journal of andrology.

[97]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[98]  Park,et al.  Effects of androgens on the expression of nitric oxide synthase mRNAs in rat corpus cavernosum , 1999, BJU international.

[99]  A. Booth,et al.  Testosterone and dominance in men , 1998, Behavioral and Brain Sciences.

[100]  A. Burnett,et al.  The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. , 1995, Fertility and sterility.

[101]  J. Rajfer,et al.  Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat. , 1995, Endocrinology.

[102]  J. Bancroft,et al.  The effects of exogenous testosterone on sexuality and mood of normal men. , 1992, The Journal of clinical endocrinology and metabolism.

[103]  E. Nieschlag,et al.  Testosterone: Action, Deficiency, Substitution , 1990 .

[104]  P. Marrama,et al.  Effects of androgen treatment in impotent men with normal and low levels of free testosterone , 1990, Archives of sexual behavior.

[105]  A. Isidori,et al.  Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility. , 1988, The Journal of clinical endocrinology and metabolism.

[106]  N. Skakkebaek,et al.  ANDROGEN REPLACEMENT WITH ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MEN: A DOUBLE BLIND CONTROLLED STUDY , 1981, Clinical endocrinology.

[107]  J. Carter,et al.  Prolactin-screening tumors and hypogonadism in 22 men. , 1978, The New England journal of medicine.

[108]  R. Bell,et al.  A Multivariate Analysis of Female Extramarital Coitus , 1975 .

[109]  William J. Norton.  Part III , 1916, Transactions of the American Institute of Electrical Engineers.